Two New FDA-Approved Treatments for RKD

FILSPARI® (sparsentan) has been FDA approved for FSGS, and TRUTAKNA® (atacicept) has been FDA approved for IgAN. More information is coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Resources

Discover our comprehensive resource hub packed with detailed information about rare kidney diseases, FAQs, helpful guides, videos, recorded webinars, and more. Whether you need information, support, or guidance, our resources aim to help empower and educate you on your journey towards better kidney health. 

Topics

Resource Type

disease type

Sponsors

Headline decoration line

Frequently Asked Questions

Have questions about kidneys, kidney disease, getting tested, and more? Here are some of the most common questions users have.

LEARN MORE

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.